Insider Selling: Kewaunee Scientific (NASDAQ:KEQU) CEO Sells 629 Shares of Stock

Kewaunee Scientific Corporation (NASDAQ:KEQU) CEO Thomas David Hull III sold 629 shares of the business’s stock in a transaction that occurred on Wednesday, December 31st. The stock was sold at an average price of $37.66, for a total value of $23,688.14. Following the completion of the transaction, the chief executive officer directly owned 35,177 shares in the company, valued at $1,324,765.82. The trade was a 1.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Thomas David Hull III also recently made the following trade(s):

• On Tuesday, December 30th, Thomas David Hull III sold 29 shares of Kewaunee Scientific stock. The shares were sold at an average price of $38.00, for a total value of $1,102.00.
• On Monday, December 29th, Thomas David Hull III sold 884 shares of Kewaunee Scientific stock. The stock was sold at an average price of $38.01, for a total value of $33,600.84.
• On Monday, December 22nd, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $39.00, for a total transaction of $39,000.00.

Kewaunee Scientific Trading Up 1.9%

KEQU traded up $0.70 during trading on Friday, reaching $38.11. 1,574 shares of the company’s stock were exchanged, compared to its average volume of 7,133. The company’s fifty day moving average price is $39.59 and its 200-day moving average price is $46.85. The firm has a market capitalization of $109.36 million, a PE ratio of 9.68 and a beta of 0.55. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.71 and a current ratio of 2.48. Kewaunee Scientific Corporation has a fifty-two week low of $30.33 and a fifty-two week high of $71.33.

Kewaunee Scientific (NASDAQ:KEQU) last posted its quarterly earnings data on Wednesday, December 10th. The technology company reported $0.91 earnings per share for the quarter. The company had revenue of $70.10 million during the quarter. Kewaunee Scientific had a return on equity of 22.39% and a net margin of 4.11%.During the same period in the prior year, the company earned $1.01 earnings per share.

Hedge Funds Weigh In On Kewaunee Scientific

Several institutional investors have recently modified their holdings of KEQU. First Trust Advisors LP raised its holdings in Kewaunee Scientific by 3.4% during the 2nd quarter. First Trust Advisors LP now owns 6,726 shares of the technology company’s stock valued at $395,000 after buying an additional 222 shares during the period. Geode Capital Management LLC grew its stake in Kewaunee Scientific by 0.9% in the second quarter. Geode Capital Management LLC now owns 24,013 shares of the technology company’s stock valued at $1,410,000 after purchasing an additional 223 shares during the last quarter. US Bancorp DE grew its holdings in Kewaunee Scientific by 80.0% in the third quarter. US Bancorp DE now owns 900 shares of the technology company’s stock worth $38,000 after purchasing an additional 400 shares during the last quarter. Bank of America Corp DE raised its holdings in shares of Kewaunee Scientific by 2,605.9% in the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock worth $28,000 after buying an additional 443 shares during the last quarter. Finally, Ritholtz Wealth Management lifted its holdings in shares of Kewaunee Scientific by 6.1% during the third quarter. Ritholtz Wealth Management now owns 13,734 shares of the technology company’s stock worth $586,000 after purchasing an additional 785 shares during the period. 32.69% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

KEQU has been the topic of several recent research reports. Wall Street Zen downgraded Kewaunee Scientific from a “buy” rating to a “hold” rating in a report on Saturday, December 13th. Weiss Ratings restated a “hold (c+)” rating on shares of Kewaunee Scientific in a report on Wednesday, October 8th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold”.

About Kewaunee Scientific

Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.